Titan Pharmaceuticals (TTNP) Competitors

Cocrystal Pharma (NASDAQ:COCP) and Titan Pharmaceuticals (NASDAQ:TTNP) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, community ranking, valuation, dividends, analyst recommendations, media sentiment, earnings and profitability.

Do analysts prefer COCP or TTNP?

Cocrystal Pharma currently has a consensus price target of $7.00, suggesting a potential upside of 357.52%. Given Cocrystal Pharma's stronger consensus rating and higher possible upside, research analysts plainly believe Cocrystal Pharma is more favorable than Titan Pharmaceuticals.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cocrystal Pharma	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Titan Pharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Which has preferable earnings & valuation, COCP or TTNP?

Titan Pharmaceuticals has higher revenue and earnings than Cocrystal Pharma. Cocrystal Pharma is trading at a lower price-to-earnings ratio than Titan Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cocrystal Pharma	N/A	N/A	-$17.98M	-$1.73	-0.88
Titan Pharmaceuticals	$180K	19.37	-$5.57M	-$5.21	-0.73

Do insiders and institutionals hold more shares of COCP or TTNP?

6.7% of Cocrystal Pharma shares are owned by institutional investors. Comparatively, 31.5% of Titan Pharmaceuticals shares are owned by institutional investors. 25.6% of Cocrystal Pharma shares are owned by company insiders. Comparatively, 24.9% of Titan Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Is COCP or TTNP more profitable?

Cocrystal Pharma's return on equity of -94.62% beat Titan Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cocrystal Pharma	N/A	-94.62%	-78.24%
Titan Pharmaceuticals	N/A	-118.01%	-103.79%

Which has more volatility and risk, COCP or TTNP?

Cocrystal Pharma has a beta of 2.21, indicating that its share price is 121% more volatile than the S&P 500. Comparatively, Titan Pharmaceuticals has a beta of 1.27, indicating that its share price is 27% more volatile than the S&P 500.

Does the MarketBeat Community favor COCP or TTNP?

Titan Pharmaceuticals received 311 more outperform votes than Cocrystal Pharma when rated by MarketBeat users. However, 77.42% of users gave Cocrystal Pharma an outperform vote while only 53.09% of users gave Titan Pharmaceuticals an outperform vote.

Company	Underperform	Outperform
Cocrystal Pharma	Outperform Votes 24 77.42%	Underperform Votes 7 22.58%
Titan Pharmaceuticals	Outperform Votes 335 53.09%	Underperform Votes 296 46.91%

Does the media refer more to COCP or TTNP?

In the previous week, Cocrystal Pharma had 1 more articles in the media than Titan Pharmaceuticals. MarketBeat recorded 3 mentions for Cocrystal Pharma and 2 mentions for Titan Pharmaceuticals. Titan Pharmaceuticals' average media sentiment score of 0.94 beat Cocrystal Pharma's score of 0.22 indicating that Titan Pharmaceuticals is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cocrystal Pharma	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Titan Pharmaceuticals	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Cocrystal Pharma beats Titan Pharmaceuticals on 10 of the 16 factors compared between the two stocks.